SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-001490
Filing Date
2018-05-21
Accepted
2018-05-21 15:43:21
Documents
41
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-033118.htm 10-Q 175937
2 CERTIFICATION proteo_ex3101.htm EX-31.1 9064
3 CERTIFICATION proteo_ex3102.htm EX-31.2 9065
4 CERTIFICATION proteo_ex32.htm EX-32 5393
  Complete submission text file 0001683168-18-001490.txt   1101658

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20180331.xml EX-101.INS 113908
6 XBRL SCHEMA FILE pteo-20180331.xsd EX-101.SCH 15232
7 XBRL CALCULATION FILE pteo-20180331_cal.xml EX-101.CAL 30522
8 XBRL DEFINITION FILE pteo-20180331_def.xml EX-101.DEF 38087
9 XBRL LABEL FILE pteo-20180331_lab.xml EX-101.LAB 100094
10 XBRL PRESENTATION FILE pteo-20180331_pre.xml EX-101.PRE 86965
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 18849461
SIC: 2834 Pharmaceutical Preparations